[ORGANIZATION]
Medicines and Healthcare products Regulatory Agency (MHRA)
Featured in 7 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
259 clusters · 928 sources · last updated
Latest: Medical experts warn of weight regain risks for GLP-1 users
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Aficamten development for hypertrophic cardiomyopathy
3 clusters · 4 sources · last updated
Latest: New therapies show promise for treating hypertrophic cardiomyopathy
The cardiac myosin inhibitor aficamten (brand name Myqorzo) is expanding its clinical application and regulatory reach for hypertrophic cardiomyopathy (HCM). In England, the Medicines and Healthcare products Regulatory
Also covered in
-
UK MHRA Issues Guidance Clarifying Regulation of AI Clinical Scribe Tools
[HEALTH] · 2 sources ·